Multicenter, Randomized, Double-Blind Study to Evaluate the Safety and Efficacy of Tigecycline vs Clindamycin for the Treatment of Complicated Skin and Skin Structure Infections, Including Those Due to MRSA, in Pediatric Subject 8-17 Years.

Trial Profile

Multicenter, Randomized, Double-Blind Study to Evaluate the Safety and Efficacy of Tigecycline vs Clindamycin for the Treatment of Complicated Skin and Skin Structure Infections, Including Those Due to MRSA, in Pediatric Subject 8-17 Years.

Withdrawn prior to enrolment
Phase of Trial: Phase III

Latest Information Update: 06 Jan 2017

At a glance

  • Drugs Tigecycline (Primary) ; Clindamycin; Vancomycin
  • Indications Methicillin-resistant Staphylococcus aureus infections; Skin and soft tissue infections
  • Focus Therapeutic Use
  • Most Recent Events

    • 06 Jan 2017 This trial has been completed in Hungary, according to European Clinical Trials Database
    • 21 Jul 2012 Additional trial locations added as reported by European Clinical Trials Database.
    • 06 Jun 2012 Status changed from suspended to withdrawn prior to recruitment as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top